Lenalidomide: Treatment for mantle cell lymphoma

Indianpharma25 Jan, 2022Health

The medicine Lenalidomide is used by doctors to treat patients with multiple myeloma who have received at least one prior therapy, transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes, follicular lymphoma, marginal zone lymphoma, and mantle cell lymphoma. FDA approved this drug in 2005. This medicine is supplied in strengths 5 mg, 10 mg, 15 mg, and 25 mg as capsules for oral administration. The active ingredient in the medicine is Lenalidomide with inactive ingredients lactose anhydrous, microcrystalline cellulose, croscarmellose sodium, and magnesium stearate. Lenalidomide price is reasonable in India, and one can purchase this medicine from multiple suppliers of generic medicines. The Indian Pharma is one of the trusted suppliers, delivering medicines globally for more than 7 years.